Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
High dose intravenous methylprednisolone "pulse" therapy in patients with rheumatoid disease. Plasma methylprednisolone levels and adrenal function.
Baylis EM, Williams IA, English J, Marks V, Chakraborty J. Baylis EM, et al. Eur J Clin Pharmacol. 1982;21(5):385-8. doi: 10.1007/BF00542323. Eur J Clin Pharmacol. 1982. PMID: 7042371
High dose intravenous methyl prednisolone (pulse therapy) in the treatment of rheumatoid disease.
Williams IA, Baylis EM, English J. Williams IA, et al. Among authors: baylis em. Scand J Rheumatol. 1981;10(2):153-5. doi: 10.3109/03009748109095288. Scand J Rheumatol. 1981. PMID: 7017916 No abstract available.
A double-blind placebo-controlled trial of methylprednisolone pulse therapy in active rheumatoid disease.
Williams IA, Baylis EM, Shipley ME. Williams IA, et al. Among authors: baylis em. Lancet. 1982 Jul 31;2(8292):237-40. doi: 10.1016/s0140-6736(82)90323-3. Lancet. 1982. PMID: 6124671 Clinical Trial.
Methylprednisolone hemisuccinate and metabolites in urine from patients receiving high-dose corticosteroid therapy.
Lawson GJ, Chakraborty J, Dumasia MC, Baylis EM. Lawson GJ, et al. Among authors: baylis em. Ther Drug Monit. 1992 Feb;14(1):20-6. doi: 10.1097/00007691-199202000-00004. Ther Drug Monit. 1992. PMID: 1546386
High-dose methylprednisolone sodium succinate (pulse therapy) in the treatment of renal disease: plasma and urine concentrations.
Searle M, Lawson G, Chakraborty J, Baylis EM, Lee HA, Marks V. Searle M, et al. Among authors: baylis em. Eur J Clin Pharmacol. 1985;28(3):245-8. doi: 10.1007/BF00543317. Eur J Clin Pharmacol. 1985. PMID: 3891379
Alteration of plasma prednisolone levels by indomethacin and naproxen.
Rae SA, Williams IA, English J, Baylis EM. Rae SA, et al. Among authors: baylis em. Br J Clin Pharmacol. 1982 Sep;14(3):459-61. doi: 10.1111/j.1365-2125.1982.tb02010.x. Br J Clin Pharmacol. 1982. PMID: 7126420 Free PMC article.
Methylprednisolone-hemisuccinate and its metabolites in serum, urine and bile from two patients with acute graft rejection.
Lawson GJ, Chakraborty J, Tredger JM, Baylis EM. Lawson GJ, et al. Among authors: baylis em. Br J Clin Pharmacol. 1995 Feb;39(2):176-8. doi: 10.1111/j.1365-2125.1995.tb04426.x. Br J Clin Pharmacol. 1995. PMID: 7742157 Free PMC article.
Effects of renal function on plasma digoxin levels in elderly ambulant patients in domiciliary practice.
Baylis EM, Hall MS, Lewis G, Marks V. Baylis EM, et al. Br Med J. 1972 Feb 5;1(5796):338-41. doi: 10.1136/bmj.1.5796.338. Br Med J. 1972. PMID: 5008659 Free PMC article.
Influence of folic acid on blood-phenytoin levels.
Baylis EM, Crowley JM, Preece JM, Sylvester PE, Marks V. Baylis EM, et al. Lancet. 1971 Jan 9;1(7689):62-4. doi: 10.1016/s0140-6736(71)90782-3. Lancet. 1971. PMID: 4099219 Clinical Trial. No abstract available.
Erythrocyte-transketolase activity in megaloblastic anaemia.
Wells DG, Baylis EM, Holoway L, Marks V. Wells DG, et al. Among authors: baylis em. Lancet. 1968 Sep 7;2(7567):543-5. doi: 10.1016/s0140-6736(68)92412-4. Lancet. 1968. PMID: 4175403 No abstract available.
16 results
Jump to page
Feedback